Industry News

newsicon-industry

News from the global pharmaceuticals industry about head lice treatments and corporate developments, including takeovers and mergers.

22.02.17 | Assessment of oral ivermectin versus shampoo in the treatment of pediculosis

A study conducted in two neighbouring villages of Sine-Saloum, Senagal, analysed the effect of using oral Ivermectin and shampoo in the treatment of pediculosis and revealed that whilst oral ivermectin is more highly effective in treating pediculosis compared with shampoo, ivermectin resitance may emerge during treatment.

15.05.17 | A randomized clinical study comparing a head lice shampoo, (Licener®) with an anti-head lice product containing dimethicone (Jacutin® Pedicul Fluid)

A new study conducted between July and November 2016 in households of two villages in Egypt compared the safety and efficacy of a shampoo-based head lice treatment (Licener®) with an anti-head lice product (Jacutin® Pedicul Fluid) via a randomized and controlled clinical study.

07.04.17 | A randomised clinical trial to evaluate the efficacy and safety of a new pediculicide made with saponified olive oil in the eradication of head lice.

A new study has compared the efficacy and safety of a new pediculicide, Inex Pediculicide Soap® with Paranix® via a randomised clinical trial involving children diagnosed with pediculosis and 6 paediatricians from the community of Madrid, Spain.

16.03.17 | Randomised trials to assess the efficacy of Australian essential oils in the treatment of head lice

A new study has compared the efficacy of a head lice treatment containing Australian eucalyptus oil and Leptospermum petersonii (EO/LP Solution) with a neurotoxic treatment containing pyrethrins and piperonyl butoxide (P/PB Mousse) via a randomised controlled study.

16.09.16 | Efficacy of Abametapir Against Eggs of Human Head and Body Lice

A study undertaken to determine the ovicidal efficacy of abametapir against eggs of both human head and body lice has revealed that abametaphir has an 100% ovicidal activity in vitro assessments and therefore able to inhibit hatching of both head and body louse eggs if used in specific concetrations.

16.09.16 | Tyratech seeing continued growth of Vamousse

TyraTech has reported an increase of 31% in sales during the first half of 2016.

18.07.16 | Stubborn egg loosening lotion launched by Hedrin

The head lice brand Hedrin has announced the launch of a Stubborn Egg Loosening Lotion and suggested that this new addition to the Hedrin family would make it easy to remove dead eggs from the hair after treatment.

22.01.16 | Safety of Oral Ivermectin in Children

New commentary warns of the risks of excessive use of ivermectin for unauthorized groups.

14.09.15 | Xeglyze submitted for FDA approval, commercialisation deal announced

Hatchtech is submitting its Xeglyze lice treatment to the FDA for approval and has signed a commercialisation agreement with Dr. Reddy’s.

08.09.15 | Updated Pediculosis Pipeline insight report

DelveInsight have released an updated report covering the state of the pediculosis treatment pipeline.

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved